DIAMEDICA THERAPEUTICS INC
Institutional coverage
86 13F filers hold $DMAC.
13F holders
86
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
2 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
01
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
0.00% held
α +27.5pts
02
Citigroup Inc.
0.00% held
α +26.3pts
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 86 · Source: 13F-HR01
Evergreen Capital Management LLC
—
935,592 sh
02
Compass Investment Advisers LLC
0.01% of portfolio
910,000 sh
03
Nvidia Corp.
8.05% of portfolio
875,000 sh
04
Axa S.a.
—
644,211 sh
05
Sheaff Brock Investment Advisors, LLC
—
639,350 sh
06
State Street
—
627,771 sh
07
Taconic Capital Advisors LP
—
226,050 sh
08
Smh Capital Advisors Inc.
—
222,444 sh
09
Encap Energy Capital Fund
0.08% of portfolio
182,850 sh
10
Atlantic Edge Private Wealth Management, LLC
—
133,872 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $DMAC in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $DMAC in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 13:06 UTC.